Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases

Overview

The primary objective of the study is to compare the effectiveness of the use of a transparent covering visor with that of the face mask, with or without the use of video sequences, for speech therapy rehabilitation of oral-linguo-facial praxies in the context of the COVID 19 epidemic.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: February 2021

Detailed Description

Statistic analysis: single case experimental design (SCED) method.

Clinical Trial Outcome Measures

Primary Measures

  • Oral-Linguo-Facial Motricity Test
    • Time Frame: throughtout of the study, an average of 2 weeks

Participating in This Clinical Trial

Inclusion Criteria

  • Aged >= 18 years; – Hospitalization for more than 2 weeks prior to enrollment in the adult post intensive care rehabilitation care unit (PICRU) of Raymond Poincaré hospital in Garches; – With oral-linguo-facial praxis disorders whatever the cause; – Has been informed and not in opposition to participation of the study. Exclusion Criteria:
  • Patient with fever or any suspect symptom of a SARS-CoV2 infection; – Planned discharge of hospital in 2 weeks; – Patient with cognitive, phasic or vigilance disorders preventing to understand the study; – Under guardianship or curator; – Patient Under french AME scheme.
  • Gender Eligibility: All

    Minimum Age: 18 Years

    Maximum Age: N/A

    Are Healthy Volunteers Accepted: No

    Investigator Details

    • Lead Sponsor
      • Assistance Publique – Hôpitaux de Paris
    • Provider of Information About this Clinical Study
      • Sponsor
    • Overall Official(s)
      • Julie PAQUEREAU, MD, Principal Investigator, Unité de Soins de Rééducation Post Réanimation, Service de Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP
    • Overall Contact(s)
      • Julie PAQUEREAU, MD, + 33 (0)1 47 10 79 00, julie.paquereau@aphp.fr

    Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

    At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.